These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21565332)
1. Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI. Feng JF; Van KC; Gurkoff GG; Kopriva C; Olszewski RT; Song M; Sun S; Xu M; Neale JH; Yuen PW; Lowe DA; Zhou J; Lyeth BG Brain Res; 2011 Jun; 1395():62-73. PubMed ID: 21565332 [TBL] [Abstract][Full Text] [Related]
2. NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxia. Feng JF; Gurkoff GG; Van KC; Song M; Lowe DA; Zhou J; Lyeth BG Brain Res; 2012 Aug; 1469():144-52. PubMed ID: 22750589 [TBL] [Abstract][Full Text] [Related]
4. NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia. Gurkoff GG; Feng JF; Van KC; Izadi A; Ghiasvand R; Shahlaie K; Song M; Lowe DA; Zhou J; Lyeth BG Brain Res; 2013 Jun; 1515():98-107. PubMed ID: 23562458 [TBL] [Abstract][Full Text] [Related]
5. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat. Zhong C; Zhao X; Van KC; Bzdega T; Smyth A; Zhou J; Kozikowski AP; Jiang J; O'Connor WT; Berman RF; Neale JH; Lyeth BG J Neurochem; 2006 May; 97(4):1015-25. PubMed ID: 16606367 [TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Yamamoto T; Hirasawa S; Wroblewska B; Grajkowska E; Zhou J; Kozikowski A; Wroblewski J; Neale JH Eur J Neurosci; 2004 Jul; 20(2):483-94. PubMed ID: 15233757 [TBL] [Abstract][Full Text] [Related]
7. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats. Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276 [TBL] [Abstract][Full Text] [Related]
8. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia. Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437 [TBL] [Abstract][Full Text] [Related]
9. Blockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders. Zhong C; Luo Q; Jiang J Int J Neurosci; 2014 Dec; 124(12):867-73. PubMed ID: 24494725 [TBL] [Abstract][Full Text] [Related]
14. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. Olszewski RT; Bukhari N; Zhou J; Kozikowski AP; Wroblewski JT; Shamimi-Noori S; Wroblewska B; Bzdega T; Vicini S; Barton FB; Neale JH J Neurochem; 2004 May; 89(4):876-85. PubMed ID: 15140187 [TBL] [Abstract][Full Text] [Related]
15. Administration of MS-275 improves cognitive performance and reduces cell death following traumatic brain injury in rats. Cao P; Liang Y; Gao X; Zhao MG; Liang GB CNS Neurosci Ther; 2013 May; 19(5):337-45. PubMed ID: 23551690 [TBL] [Abstract][Full Text] [Related]
16. Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury. Gao Y; Xu S; Cui Z; Zhang M; Lin Y; Cai L; Wang Z; Luo X; Zheng Y; Wang Y; Luo Q; Jiang J; Neale JH; Zhong C J Neurochem; 2015 Jul; 134(2):340-53. PubMed ID: 25872793 [TBL] [Abstract][Full Text] [Related]
17. Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family. Neale JH; Olszewski RT; Zuo D; Janczura KJ; Profaci CP; Lavin KM; Madore JC; Bzdega T J Neurochem; 2011 Aug; 118(4):490-8. PubMed ID: 21644997 [TBL] [Abstract][Full Text] [Related]
18. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia. Profaci CP; Krolikowski KA; Olszewski RT; Neale JH Psychopharmacology (Berl); 2011 Jul; 216(2):235-43. PubMed ID: 21327758 [TBL] [Abstract][Full Text] [Related]
19. Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents. Pandya JD; Pauly JR; Nukala VN; Sebastian AH; Day KM; Korde AS; Maragos WF; Hall ED; Sullivan PG J Neurotrauma; 2007 May; 24(5):798-811. PubMed ID: 17518535 [TBL] [Abstract][Full Text] [Related]